Zura Bio Limited (ZURA)
(Delayed Data from NSDQ)
$4.38 USD
+0.23 (5.54%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $4.40 +0.02 (0.46%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Zura Bio Limited falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -60.56 | 3.55 | 6.85 | NA | NA |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change from Assets/Liabilities | 5.12 | 1.60 | -0.24 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 40.39 | -6.22 | -7.71 | NA | NA |
Net Cash From Operating Activities | -15.05 | -1.07 | -1.10 | NA | NA |
Property & Equipment | 0.00 | 0.00 | 0.00 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 0.00 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | -8.00 | 0.00 | -139.38 | NA | NA |
Net Cash from Investing Activities | -8.00 | 0.00 | -139.38 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 132.48 | 0.00 | 138.03 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | -10.00 | 0.36 | -0.12 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | -1.18 | 0.00 | 3.30 | NA | NA |
Net Cash from Financing Activities | 121.29 | 0.36 | 141.21 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | 98.24 | -0.72 | 0.73 | NA | NA |
Cash at Beginning of Period | 1.57 | 0.73 | 0.00 | NA | NA |
Cash at End of Period | 99.81 | 0.01 | 0.73 | NA | NA |
Diluted Net EPS | -2.09 | 0.21 | 0.61 | NA | NA |
Fiscal Year End for Zura Bio Limited falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -18.08 | -7.75 | -60.56 | -52.09 | -43.82 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -0.21 | -0.23 | 5.12 | 2.11 | -0.73 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.68 | 2.99 | 40.39 | 38.98 | 36.12 |
Net Cash From Operating Activities | -11.60 | -4.98 | -15.05 | -11.00 | -8.43 |
Property & Equipment | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -5.00 | -5.00 | -8.00 | -8.00 | -5.75 |
Net Cash from Investing Activities | -5.02 | -5.01 | -8.00 | -8.00 | -5.75 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 105.25 | 0.00 | 132.48 | 132.48 | 136.60 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -10.00 | -10.00 | -10.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -1.18 | -1.18 | -1.18 |
Net Cash from Financing Activities | 105.25 | 0.00 | 121.29 | 121.29 | 125.42 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 88.64 | -9.99 | 98.24 | 102.29 | 111.24 |
Cash at Beginning of Period | 99.81 | 99.81 | 1.57 | 1.57 | 1.57 |
Cash at End of Period | 188.44 | 89.82 | 99.81 | 103.86 | 112.80 |
Diluted Net EPS | -0.17 | -0.02 | 2.16 | -0.18 | -1.31 |